What's Happening?
German startup TimeTeller has developed a saliva test kit designed to help individuals understand their circadian rhythm, aiming to personalize medicine. The company, led by CEO Angela Relógio, a physicist-engineer and molecular biologist, focuses on using
individual circadian data to offer tailored advice on sleep, nutrition, light exposure, and physical activity. While TimeTeller's long-term goal is to optimize cancer treatments by timing them to each patient's internal clock to reduce side effects and improve outcomes, its direct-to-consumer kit currently provides personalized advice for healthy aging. Relógio's discovery, which led her to leave academia, stemmed from observing cancer patients discontinuing treatment due to side effects, believing that the timing of treatment could be as crucial as the treatment itself. TimeTeller has secured a partnership with Techniker Krankenkasse, one of Germany’s largest health insurance providers, initially for reimbursement of the test for a subset of cancer patients, with plans to expand to more members.
Why It's Important?
TimeTeller's innovation represents a significant step towards personalized medicine by integrating an individual's circadian rhythm into health management. The ability to tailor advice on sleep, nutrition, and physical activity based on one's internal clock could lead to more effective health interventions and improved well-being. For the healthcare industry, this approach could revolutionize how treatments are administered, particularly in oncology, by potentially reducing adverse effects and enhancing therapeutic efficacy. This could lead to better patient compliance and overall treatment success, ultimately lowering healthcare costs associated with managing side effects and treatment failures. The partnership with a major health insurance provider in Germany highlights the growing recognition of circadian biology's importance in clinical practice and could pave the way for broader adoption of such personalized diagnostic tools in the U.S. and globally. The focus on healthy aging and chronic diseases like diabetes and Alzheimer's also positions TimeTeller at the forefront of preventive and precision health.
What's Next?
TimeTeller plans to expand its partnership with Techniker Krankenkasse to include more of the insurer's 12 million members, indicating a growing acceptance and integration of circadian rhythm testing into mainstream healthcare. The company's long-term ambition is to determine the optimal timing for cancer treatments to improve tolerability and effectiveness, which will require further clinical studies to calculate specific timing for each medicine. While the direct-to-consumer kit offers personalized advice for healthy aging, it will not independently help patients time their cancer treatments. Relógio emphasized that such calculations must be done within the context of clinical studies. TimeTeller's presence at TechCrunch Disrupt in San Francisco underscores its ambitions for broader reach and potential U.S. market entry. The company's vision is to make the question of 'when' central to precision medicine, recognizing that almost every bodily process is timed.
Beyond the Headlines
TimeTeller's approach highlights the ethical and scientific considerations surrounding at-home health testing, particularly in a landscape previously marred by overblown claims. Relógio's cautious stance on what the test can and cannot do today, especially regarding cancer treatment timing, reflects a commitment to scientific rigor and responsible innovation. The concept of chronomedicine, where treatments are timed to the body's natural rhythms, has profound implications for drug development and patient care, moving beyond a one-size-fits-all model. This could lead to a re-evaluation of existing treatment protocols across various medical fields. Furthermore, the emphasis on individual data for personalized advice on lifestyle factors like sleep and nutrition empowers individuals to take a more active role in managing their health, fostering a more proactive and preventive healthcare paradigm. The integration of circadian biology into personalized medicine could also spark new research into the environmental and genetic factors that influence our internal clocks.
